Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, July 28, 2026

Snapshot: Jul 28, 2026 · 6:00 PM 100 stocks analyzed

Strong Down Day

Tue, Jul 28, 2026 Broad Selloff High

Nasdaq-100 crashed 4.8% in a broad tech-led selloff as fear spiked and dispersion hit highs, though a few beaten-down names found rescue bids.

60% Tech-driven broad market collapse with Nasdaq down 3.7% and Nasdaq-100 plunging 4.8%, led by mega-cap weakness that triggered a 9.4% VIX spike despite the S&P 500's more modest 1.1% decline; NASDAQ outpaced downside, signaling capital fleeing equities entirely rather than rotating to safety.
25% Extreme single-stock dispersion with 50 gainers averaging +24% (led by STFS +84%, ONMD +51%, VRRM +32%) and 50 losers averaging -26% (AACI -77%, YYAI -71%, BIOT -53%), creating a wild two-tier market where individual catalysts mattered far more than broad sentiment.
15% Persistent losers now in their third consecutive day underwater (BRUNW, VCIG, AMPGZ) alongside fresh debutants surging on earnings beats or capital raises (ITRI +26% on earnings, KNSA +24% on Kiniksa upbeat Q2, ONMD +51% on healthcare data deal), suggesting dispersion will remain elevated until rotation clarifies.

Technology drove 33% of gainers 5 names returned after long absences BRUNW · 3-day losers streak VCIG · 3-day losers streak CJET — first appearance DFSCW — first appearance

Market Regime

Tue, Jul 28, 2026 Neutral conf: medium macro · prototype

-18

Headwind −100 … +100 · + tailwind / − headwind

VIX18.2 p72 Drawdown-2.4% Held1d · nascent SinceJul 28

Top drivers: VIX percentile ▼ Small-cap leadership ▼ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Tue, Jul 28, 2026 13

S&P 500

7,428.78

−80.42

-1.07%

Dow Jones

52,747.32

+522.68

+1.00%

NASDAQ Composite

24,876.91

−960.30

-3.72%

NASDAQ 100

27,763.14

−1,392.05

-4.77%

DJ US Total Market

73,626.35

−772.70

-1.04%

Russell 1000

4,048.26

−39.74

-0.97%

S&P MidCap 400

3,798.37

+14.14

+0.37%

Russell 2000

2,953.80

−33.60

-1.12%

Russell 2500

1,263.27

+3.86

+0.31%

Russell 3000

4,229.42

−41.79

-0.98%

Nasdaq Financial-100

7,502.05

+76.02

+1.02%

NIFTY 50

23,985.35

−10.90

-0.05%

VIX

18.21

+1.57

+9.44%

Biggest Gainers

Tue, Jul 28, 2026 50

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$3.58+$2.70

+84.4%

NASDAQ · Mkt cap $5.3 M

No news headlines were available in the last 48 hours to explain the 84% gain, so the cause remains unknown; this type of move on a small-cap fashion stock typically reflects either delayed news absorption, technical/short-squeeze activity, or undisclosed corporate developments.

Star Fashion Culture Holdings experienced a dramatic single-day surge of 84.38% to rank as the top gainer on NASDAQ, yet no news headlines appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect between magnitude of move and absence of public news is notable. In such cases, several categories of catalyst are plausible but unconfirmed: a press release or SEC filing may have been issued but not yet indexed by mainstream financial news feeds; the stock may be subject to short-squeeze dynamics given typical liquidity constraints on micro-cap apparel companies; or an earnings report, partnership announcement, or operational development occurred outside the monitored news window. Without access to real-time SEC filings, company press releases, or social media sentiment, attribution remains speculative. The fashion retail sector is cyclical and often subject to momentum trading, which could amplify such moves independent of fundamental news.

DFNS

Defense Industries International IncIndustrials

$24.00+$10.46

+77.3%

NYSE · Mkt cap $27 M

No news headlines were found in the last 48 hours to explain the 77% jump in DFNS stock, so the driver remains unclear without access to additional information sources or company announcements.

The absence of any recent news headlines is notable given the magnitude of the move—a 77% single-day gain for a defense contractor typically requires substantive catalyst. Defense stocks commonly react to contract awards, geopolitical events, earnings surprises, guidance raises, or acquisition rumors. Without news from Yahoo Finance's feeds, the move could reflect several categories: a material company announcement (earnings, guidance, or contract win) released through channels not yet indexed by the RSS feed, a significant intraday rumor or social media event, technical buying pressure from short covering or options expiry dynamics, or delayed market reaction to news from earlier in the week. Defense sector strength more broadly could also amplify an individual stock move if sector rotation drove multiple names higher simultaneously. However, these remain hypotheses rather than confirmed causes.

ONMD

OneMedNet CorpHealthcare

$0.70+$0.31

+51.2%

NASDAQ · Mkt cap $35 M

OneMedNet announced a $11.5+ million agreement to supply regulatory-grade real-world data for AI model development, validating its position as a premier healthcare data supplier and driving the 51% intraday surge.

The company disclosed on July 28 a material contract worth over $11.5 million to provide high-quality, regulatory-grade healthcare data for foundational AI model training. This announcement directly validates OneMedNet's core business model as a supplier of structured medical data to AI developers—a high-demand market segment given the current focus on healthcare-focused large language models and machine learning applications. For a micro-cap stock trading near $0.70, a contract of this magnitude represents meaningful revenue visibility and proof of commercial traction. The timing of the release and the stock's same-day ranking as the third-largest gainer strongly suggests the market reacted positively to both the contract itself and the implicit signal that OneMedNet has successfully monetized its data assets in the AI era.

AMIX

Autonomix Medical, Inc. Common StockHealthcare

$2.76+$1.25

+47.5%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 47.53% jump in AMIX cannot be directly attributed to a disclosed event. The move likely reflects either a delayed market reaction to an earlier announcement, technical trading, or an undisclosed catalyst.

Yahoo Finance returned zero headlines for AMIX in the past 48 hours, making it impossible to connect the stock's strong gain to a specific news event. A 47.53% single-day surge in a small-cap medical device company typically correlates with major catalysts such as FDA approvals, clinical trial results, partnership announcements, or positive earnings surprises. Without available headlines, the move could reflect several possibilities: a press release issued outside the standard news feed window, short covering in a thinly traded stock, retail trading activity, or market makers repricing the security based on private information. It is also possible that relevant news was distributed via company channels rather than broad financial news wires, making it invisible to this search.

CNET

ChinaNet Online Holdings IncCommunication Services

$1.41+$0.41

+41.7%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 41.72% jump in CNET stock cannot be attributed to a disclosed catalyst; the cause remains unknown without additional information.

ChinaNet Online Holdings experienced a significant single-day rally of over 41 percent with zero news coverage in the recent window. This disconnect between a major price move and an absence of headline-driven catalysts suggests either a delayed market reaction to older news, a technical or sentiment-driven event, short covering on a thinly traded small-cap stock, or undisclosed developments not yet reflected in major news feeds. CNET trades on NASDAQ at a very low price point (1.41 dollars), which typically indicates either a distressed situation or a micro-cap security prone to volatility. Micro-cap stocks frequently experience outsized moves on limited volume and rumor, earnings surprises, or short squeezes. Without concrete news, identifying the precise trigger is not possible from the available evidence.

TGE.WT

The Generation Essentials Group

$0.18+$0.05

+38.5%

NYSE

No news headlines were available in the last 48 hours, so the 38% gain cannot be directly attributed to a specific corporate announcement or market event. The move is likely driven by technical factors, retail interest, or untracked information.

TGE.WT is a warrant security trading at a very low price point of $0.18, which makes it highly susceptible to outsized percentage moves on modest absolute dollar volume. Warrant securities are leveraged instruments that amplify underlying stock movements, and micro-cap stocks at penny price levels frequently experience volatile swings driven by retail trading, short covering, or technical breakouts rather than fundamental news. Without any reported headlines in the last 48 hours, this move cannot be anchored to earnings, guidance, acquisitions, or regulatory events. The absence of news coverage combined with the security's warrant structure and penny-stock characteristics suggests the gain may reflect technical momentum, algorithmic trading, or information not yet captured by major news feeds, rather than a specific corporate development.

NEXR

Nexera Technologies Ltd.Consumer Cyclical

$0.34+$0.09

+36.5%

DCX

Chijet Motor Company, Inc.Consumer Cyclical

$0.97+$0.25

+34.9%

NASDAQ · Mkt cap $322 M

No headlines were found in the last 48 hours, so the 34.88% jump in DCX cannot be attributed to any disclosed news event. The move likely reflects technical trading, sector rotation, or unconfirmed market rumors.

DCX showed a strong single-day gain of 34.88%, ranking it among the top gainers on NASDAQ, but no corresponding news headlines appeared in the available 48-hour window. This disconnect suggests the price action was driven by factors other than publicly announced company developments. For a micro-cap or penny stock like DCX trading near $1, such moves commonly reflect short covering, retail trading momentum, sector-wide rallies in automotive or EV-related stocks, or revival of interest following a prior sell-off. Without access to intraday volume data, options activity, or broader market context, it is not possible to pinpoint whether this was technical accumulation, a delayed response to older news, or speculative trading driven by social media or message boards rather than official disclosures.

VRRM

Verra Mobility CorpTechnology

$4.19+$1.33

+32.4%

NASDAQ · Mkt cap $619 M

Verra Mobility surged 32% after announcing a framework agreement with Avis Budget Group on new commercial terms, signaling a significant business partnership that likely boosted investor confidence in the company's smart mobility platform.

The headline confirms Verra Mobility reached a framework agreement with Avis Budget Group on key commercial terms for a new service offering. While the full details are truncated in the RSS feed, such partnerships are typically material for mobility tech providers because they represent large-scale deployment opportunities and recurring revenue streams. Avis is a major car rental operator, so a framework agreement suggests Verra's technology will be integrated into a significant fleet, which could drive adoption and future earnings. The 32% single-day gain is consistent with investor enthusiasm for concrete business development wins that validate the company's market position and revenue visibility. The ranking as the ninth biggest gainer suggests the move drew broad market attention, though the exact commercial terms and scope remain partially unclear from the headline alone.

CISS

C3is Inc. - Common StockIndustrials

$0.17+$0.04

+29.9%

NASDAQ · Mkt cap $4.6 M

C3is Inc. announced pricing of a $6.0 million underwritten public offering on July 27, which likely drove the 29.89% gain as investors reacted positively to the capital raise and potential business expansion for this shipping services company.

The headline explicitly states that C3is priced an underwritten public offering of $6.0 million on July 27, 2026, the day before the observed price jump. For a micro-cap stock trading at $0.17, a capital raise of this magnitude represents meaningful liquidity and growth capital. The positive market reaction suggests investors viewed the offering as a positive catalyst—either because the company found investors willing to fund growth initiatives, the offering was oversubscribed, or the market interpreted it as a sign of business confidence and stability. The news was released during market hours on July 27 and the stock moved higher the following day, consistent with a news-driven rally. However, the full text of the announcement is truncated, so details about pricing terms, number of shares issued, or use of proceeds are not visible here, limiting the depth of analysis possible.

APUS

Apimeds Pharmaceuticals US, IncHealthcare

$8.00+$1.71

+27.2%

NYSE · Mkt cap $6.0 M

No news headlines were found in the last 48 hours, so the 27% gain on July 28 cannot be directly attributed to a reported catalyst. The move likely reflects a positive development not yet captured in major news feeds, technical buying, or market rumor.

APUS is a small-cap pharmaceutical stock and lacks any recent headline coverage in the provided news source. A 27% single-day move in a pharma stock of this size can be triggered by several categories of events: clinical trial results or regulatory announcements posted directly to company channels before broad media pickup, short covering or technical momentum, insider activity disclosed after-hours, or market rumors circulating on forums or direct communication channels that haven't yet reached mainstream financial news. Without documented headlines, it is impossible to determine which category applies here. The absence of news does not rule out a material catalyst; it merely means the evidence is not available in this dataset.

CJET

Chijet Motor Company IncConsumer Cyclical

$0.93+$0.20

+26.9%

DFSCW

DEFSEC Technologies Inc.Industrials

$0.02+$0.00

+26.9%

ITRI

Itron IncTechnology

$106.99+$22.16

+26.1%

NASDAQ · Mkt cap $4.2 B

Itron beat Q2 earnings estimates significantly with record gross margins and raised full-year 2026 EPS guidance, offsetting a modest revenue miss that was due to project timing rather than fundamental weakness.

Itron reported Q2 2026 earnings that exceeded analyst profitability expectations by 22.31% despite revenue coming in slightly below estimates at $562.9 million, down 7.2% year-over-year. The key driver of the 26% stock surge was the company's achievement of record gross margins and higher adjusted EBITDA alongside an increase in its full-year 2026 earnings outlook. Management highlighted strong recurring revenue growth and a healthy backlog, with the revenue decline attributed to timing of project deployments and regulatory processes rather than fundamental business deterioration. The combination of operational leverage demonstrated through margin expansion, a raised earnings guidance for the full year, and narrative clarity around the YoY revenue timing issues likely convinced investors that the stock had been oversold heading into earnings and that the company's profitability trajectory remains intact despite near-term project headwinds.

CHAI

Defiance Israel Bond ETFCommunication Services

$0.47+$0.10

+25.6%

NYSE · Mkt cap $6.8 M

Core AI Holdings (ticker CHAI) announced an expansion of its strategic partnership with TikTok on July 28, 2026, to strengthen AI-driven distribution infrastructure, likely driving the 25.64% intraday gain in the ETF that shares its ticker symbol.

Two nearly identical press releases from Core AI Holdings were published on July 28, both announcing an expanded TikTok partnership focused on AI-powered customer acquisition, digital advertising, and cross-platform distribution. However, a critical distinction exists: the security trading as CHAI on NYSE is the Defiance Israel Bond ETF, a fixed-income fund with no operational connection to Core AI Holdings, which trades on NASDAQ under the same ticker symbol. The stock price movement of CHAI (NYSE) appears to be a ticker-symbol collision effect. Investors searching for Core AI Holdings (NASDAQ:CHAI) news may have inadvertently purchased or driven volume in the Israel Bond ETF instead, or algorithmic systems may have cross-referenced the two tickers. The TikTok partnership expansion itself is substantive corporate news for Core AI, but it should not directly affect the bond ETF's valuation unless the confusion triggered genuine reallocation flows.

KNSA

Kiniksa Pharmaceuticals LtdHealthcare

$79.15+$15.62

+24.6%

NASDAQ · Mkt cap $6.3 B

Kiniksa reported Q2 earnings on July 28 with ARCALYST revenue up 55% year-over-year to $243.6 million, raised full-year guidance, and advanced its cardiovascular pipeline, driving a 24.58% stock gain.

The earnings release and accompanying call summary provided concrete catalysts for the jump. ARCALYST, the company's flagship drug, delivered $243.6 million in quarterly revenue, representing approximately 55% year-over-year growth and a sequential increase of more than $29 million from Q1. Management raised its full-year 2026 ARCALYST sales guidance to a range of $980–$995 million, signaling confidence in continued momentum. Additionally, Kiniksa advanced KPL-387, a Phase 3 cardiovascular candidate, into clinical development. While earnings matched consensus EPS estimates and beat revenue estimates by 7.09%, the strong operational metrics—particularly the substantial ARCALYST growth trajectory and raised guidance—appear to have driven investor optimism about future earnings and the expanding pipeline, justifying the significant single-day rally.

PMN

ProMIS Neurosciences, Inc.Healthcare

$14.57+$2.81

+23.8%

NASDAQ · Mkt cap $131 M

ProMIS released positive six-month interim data from its Phase 1b Alzheimer's trial on July 28, showing no amyloid-related imaging abnormalities (ARIA-E) and early biomarker movement, which drove the 23.84% gain.

The stock jumped sharply following ProMIS's announcement of blinded interim safety and biomarker results from the PRECISE-AD Phase 1b trial of PMN310. The headline finding was the absence of ARIA-E across all patient genotypes, including the high-risk APOE4 homozygotes, which is a significant safety milestone in Alzheimer's antibody development. ARIA-E is a known side effect of amyloid-targeting therapies that had limited prior Alzheimer's programs. The company also reported early biomarker movement consistent with target engagement and no tracking above background rates for ARIA-H. Full 12-month results are expected in Q1 2027. For a clinical-stage biotech stock, positive Phase 1b safety data with biomarker evidence of mechanism represents a meaningful de-risking event that justifies investor enthusiasm.

AFJKR

Aimei Health Technology Co., Ltd Right

$0.12+$0.02

+22.0%

PSQH

Psq Holdings IncTechnology

$3.71+$0.65

+21.2%

NYSE

PSQ Holdings announced it will sell its EveryLife direct-to-consumer baby products unit for $5.5 million in cash, a strategic divestiture likely interpreted by the market as a step toward operational streamlining or debt reduction.

On July 28, 2026, PSQ Holdings announced a definitive agreement to sell EveryLife, described as its direct-to-consumer diaper and baby products business, for $5.5 million in cash. The same day the company also announced it would hold a conference call to discuss second quarter 2026 financial results on July 30. The asset sale appears to be the primary driver of the 21.24% gain. Markets often reward divestitures when they signal management is taking decisive action to focus the business, reduce complexity, or raise capital for higher-priority uses such as debt reduction or returning capital to shareholders. Without knowing the carrying value of EveryLife on the balance sheet, the company's leverage, or forward guidance, it is difficult to quantify the financial impact. However, the timing and explicit announcement suggest investors view this as a positive signal about capital allocation discipline. The pending earnings call may provide additional context on the strategic rationale.

IOTR

iOThree Limited Ordinary SharesCommunication Services

$3.03+$0.64

+20.9%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 20.92% gain on IOTR cannot be directly attributed to a specific corporate announcement or event based on available information.

The absence of any Yahoo Finance headlines in the past 48 hours makes it impossible to tie this significant 20.92% move to a concrete catalyst such as earnings, guidance, FDA approval, partnership announcement, or acquisition news. For a micro-cap or thinly-traded NASDAQ stock like iOThree Limited, large single-day moves can result from several non-news-related mechanisms: technical bounces after oversold conditions, algorithmic or short-covering activity, options expiration dynamics, or delayed announcements not yet picked up by major news feeds. Without visibility into the company's recent filings, insider activity, or social media catalysts, any explanation remains speculative. The move itself is real and material—ranking 20th among NASDAQ gainers—but its root cause remains unknown from the evidence provided.

NBRGR

Newbridge Acquisition Limited Rights

$0.22+$0.04

+20.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 20% gain is unexplained by reported corporate events. The move may reflect technical trading activity, delayed news dissemination, or market speculation typical of low-priced SPAC-related securities.

Newbridge Acquisition Limited Rights is a SPAC-related instrument trading at $0.22, a price point typical of distressed or speculative equity securities. The absence of any news in the last 48 hours means we cannot attribute the jump to earnings, guidance, M&A activity, or regulatory action. For a rights offering tied to a blank-check acquisition vehicle, price moves of this magnitude can reflect several categories: delayed news not yet indexed by major feeds, technical trading driven by moving averages or support levels breaking, retail or algorithmic buying pressure following other market catalysts, or speculation about an upcoming merger announcement or company emergence. Without access to Level 2 data, recent SEC filings, or SPAC tracking news sources, the specific trigger remains unknown.

ATXI

Avenue Therapeutics IncHealthcare

$0.30+$0.05

+20.0%

NASDAQ · Mkt cap $824 K

No news headlines appeared in the last 48 hours, so the 20% gain cannot be attributed to a reported event; the move likely reflects technical trading, delayed news dissemination, or market speculation in a micro-cap biotech stock.

Avenue Therapeutics is a small-cap biopharmaceutical company, and no recent news headlines were provided to explain the sharp 20% single-day rally. Without a specific catalyst identified in available news feeds, the move falls into several possible categories typical for micro-cap stocks: technical buying pressure or short covering (common in illiquid names), delayed disclosure of earlier announcements not yet indexed by financial news aggregators, clinical trial updates released through the company's own channels rather than major wires, or sector-wide biotech momentum. Small-cap therapeutics stocks can also be sensitive to early-stage buzz on social media or message boards that precedes formal news coverage. Without corroborating headlines, attributing this move to fundamentals is speculative.

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$2.77+$0.45

+19.6%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours, so the 19.56% gain cannot be attributed to a specific reported event. The move likely reflects technical trading, delayed news dissemination, or market speculation.

Yahoo Finance returned no headlines for LHSW in the 48 hours preceding this snapshot, making it impossible to anchor the price jump to a specific catalyst. Lianhe Sowell is a small-cap NASDAQ-listed company, and stocks in this category can experience outsized moves on relatively light volume from technical rebounds, short covering, or retail trading activity. The stock may have responded to news that has not yet been indexed by the RSS feed, or the move could reflect a sector-wide shift affecting micro-cap international holdings. Without visibility into trading volume, short interest, or intraday order flow, we cannot distinguish between a genuine announcement delayed in reaching financial headlines versus pure technical or momentum-driven activity.

MPLT

MapLight Therapeutics, Inc.Healthcare

$12.31+$1.94

+19.2%

NASDAQ · Mkt cap $525 M

MapLight stock surged 19% today despite a major trial setback announced yesterday, likely driven by short-covering or bargain-hunting after the 73% crash wiped out over $1 billion in market cap on the failed once-daily dosing regimen.

The news establishes a clear negative catalyst: MapLight's Phase II ZEPHYR trial for schizophrenia drug ML-007C-MA met its primary endpoint only with a twice-daily dose, while the commercially preferred once-daily dose failed. This triggered a 73% collapse on July 27. Today's 19% gain appears paradoxical given the same news context. The most likely explanation is a technical rebound: the stock fell so sharply that short-sellers took profits, or bargain hunters entered believing the twice-daily formulation still has value for registration and commercialization. The twice-daily endpoint success is genuine clinical progress, even if the once-daily miss is a significant setback. Biotech stocks frequently experience sharp reversals after catastrophic single-day declines, especially when some positive data remains in the wreckage.

PRLD

Prelude Therapeutics IncorporatedHealthcare

$4.62+$0.73

+18.6%

NASDAQ · Mkt cap $449 M

No news headlines were found in the last 48 hours, so the 18.64% gain cannot be attributed to a specific disclosed catalyst. The move likely reflects either technical trading, a delayed market reaction to an earlier announcement, or unconfirmed speculation.

Yahoo Finance returned no headlines for Prelude Therapeutics in the past 48 hours, which means we cannot point to earnings, clinical trial results, FDA actions, partnership announcements, or guidance changes as the cause of this substantial intraday gain. For a biotech company like PRLD, typical catalysts include clinical trial data releases, regulatory decisions, financing announcements, or strategic partnerships. The absence of news coverage suggests either that any catalyst occurred before the 48-hour window, that the market is responding to social media discussion or trading momentum rather than disclosure, or that a material announcement has not yet been widely reported by major financial news outlets. Without corroborating information, it is difficult to determine whether this move is fundamentally justified or driven by technical factors.

OPK

OPKO Health IncHealthcare

$1.65+$0.25

+18.2%

NASDAQ · Mkt cap $1.2 B

OPKO Health surged 18.25% following Q2 earnings that beat both EPS and revenue estimates, driven by strong pharmaceutical growth, Nicoya income contribution, and a narrowed net loss despite diagnostics headwinds.

The stock rally is clearly anchored to the Q2 2026 earnings release on July 27-28. Multiple headlines confirm OPKO delivered an 87.50% earnings surprise and a 24.68% revenue beat against consensus estimates. The earnings call highlights emphasize three positive drivers: significant pharmaceutical revenue growth, income contributions from the Nicoya acquisition, lower operating costs, and a narrower quarterly loss. Management also referenced a China commercialization agreement that boosted revenue. While diagnostics segment challenges are noted, the overall beat on both top and bottom lines, combined with margin improvement, appears sufficient to trigger short-covering and positive sentiment among investors who had likely positioned for a miss or flat result. The 18.25% gain places OPK among the day's top 26 gainers, suggesting broad-based institutional and retail buying into the better-than-expected results.

PCSA

Processa Pharmaceuticals, Inc.Healthcare

$3.08+$0.48

+18.2%

NASDAQ · Mkt cap $7.0 M

No news headlines are available for the last 48 hours, so the 18.23% gain cannot be directly attributed to a specific announced catalyst. The move likely reflects either delayed market reaction to an earlier event, technical positioning, or an untracked development.

Processa Pharmaceuticals is a small-cap pharmaceutical company with limited float and trading volume, making it susceptible to amplified moves on modest activity or sentiment shifts. The absence of any news in the last 48 hours means the spike is not grounded in a disclosed event like clinical trial results, FDA approval, partnership announcement, or earnings. For stocks of this profile, a strong single-day gain without concurrent headlines typically reflects one of a few scenarios: accumulated buying pressure from investors reacting to earlier news that may not yet appear in headline feeds, short covering if the stock carries notable short interest, or technical chart break-outs triggering algorithmic or retail momentum. Without visibility into volume patterns, short interest levels, or any corroborating news across other sources, we cannot pinpoint which mechanism is at work here.

LCID

Lucid Group, Inc.Consumer Cyclical

$7.92+$1.18

+18.2%

NASDAQ · Mkt cap $1.8 B

Saudi Prince Alwaleed bin Talal's $129.5 million stake purchase in Lucid, disclosed in an SEC filing on July 28, directly triggered the 18%+ intraday surge as a high-profile vote of confidence in the troubled EV maker.

Multiple headlines on July 28 confirm that Prince Alwaleed acquired a 5% beneficial ownership stake (19.5 million Class A shares) in Lucid Group, filed with the SEC on Tuesday. This announcement generated immediate buying pressure, with intraday gains reported as high as 25% before settling at the reported +18.15%. The headlines consistently attribute the stock jump to this single catalyst—a major Saudi billionaire backing the company weeks after bankruptcy rumors. The timing is precise: the filing disclosure occurred during market hours and news outlets published the story within minutes, correlating directly with the price surge. Notably, the headlines also mention Lucid faces a fraud lawsuit, earnings uncertainty, and prior 70% annual losses, yet the market responded positively to the Saudi capital infusion, treating it as validation of the company's viability despite headwinds.

SYTA

Siyata Mobile Inc.Communication Services

$0.47+$0.07

+18.1%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours to explain Siyata Mobile's 18.15% gain, so the driver remains unclear; the move may reflect technical buying, delayed market reaction to an earlier event, or untracked news.

Siyata Mobile gained 18.15% to reach $0.47 on July 28, 2026, but no financial news appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This absence of headline coverage makes direct attribution impossible. Siyata is a small-cap mobile communications device manufacturer, and stocks at this scale can move sharply on limited volume without corresponding press coverage. Common catalysts for such moves include technical or short-covering rallies, delayed market digestion of a prior announcement, analyst upgrades not yet syndicated broadly, insider activity, or rumors circulating in retail or social media channels. Without specific news or knowledge of the stock's technical setup, short interest level, or float characteristics, any explanation remains speculative.

GFUZ

General Fusion Group Ltd.Industrials

$8.59+$1.37

+18.0%

NASDAQ · Mkt cap $649 M

No headlines were found in the last 48 hours for GFUZ, so the 17.98% jump cannot be attributed to a specific news event based on available information. The move likely reflects technical trading, delayed news dissemination, or market rumors.

The absence of recent headlines in Yahoo Finance's RSS feed within the last 48 hours means we cannot identify a concrete news catalyst for this 17.98% gain. General Fusion Group is a private-equity-backed advanced fusion energy company, and stocks in the alternative energy and fusion sectors can be volatile and subject to technical rebounds, short-covering, or delayed reporting of developments. The jump ranks it among the top 30 gainers, suggesting meaningful sector interest or momentum. Without headline confirmation, the move could stem from a positive announcement not yet indexed by Yahoo's feed, insider trading activity becoming public, analyst upgrade, or simply technical momentum in a speculative growth stock. We cannot rule out any of these without additional evidence.

AMSS

AMASS Brands Inc.Consumer Defensive

$1.07+$0.16

+17.6%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 17.57% gain likely reflects a technical rebound, thin trading liquidity, or an unannounced catalyst not yet captured by major news feeds.

The absence of any news in the recent 48-hour window makes it impossible to link the move to a specific company-driven catalyst such as earnings, guidance, product launches, or partnership announcements. AMASS Brands trades at a relatively low share price of $1.07, which typically indicates a micro or small-cap stock vulnerable to outsized percentage moves on modest absolute dollar volume. Stocks in this category often experience sharp rallies due to technical oversold conditions, short covering, or retail interest in low-priced securities. Another possibility is that a material announcement or filing occurred but has not yet been indexed by the financial news aggregators covered here. Without access to the company's investor relations channels or regulatory filings in real time, we cannot rule out a recent press release, earnings surprise, or SEC filing as the driver.

BOT

RoboStrategy, Inc.Financial Services

$30.53+$4.55

+17.5%

NASDAQ · Mkt cap $665 M

No news headlines were published in the last 48 hours, so the 17.51% gain cannot be attributed to a disclosed catalyst. The move likely reflects either delayed coverage of a prior announcement, technical buying, or market rumor.

RoboStrategy, Inc. experienced a significant one-day rally ranking 32nd among NASDAQ gainers, yet zero news appeared in the 48-hour window provided. This disconnect suggests either that the catalyst occurred before the snapshot window, that market participants are reacting to information not yet widely distributed through major news feeds, or that the move is driven by technical factors such as short covering or algorithmic buying. For a robotics or automation-focused company like RoboStrategy, typical catalysts would include earnings beats, new contract announcements, product launches, or strategic partnerships. Without confirmed headlines, attributing the move to any specific event would be speculation. The stock's rank as a top 50 gainer suggests meaningful volume and conviction behind the move, but the cause remains unclear from available information.

WBUY

WEBUY GLOBAL LTD. - Ordinary SharesConsumer Cyclical

$0.89+$0.13

+17.4%

NASDAQ · Mkt cap $4.2 M

No news headlines were found in the last 48 hours to explain WBUY's 17.43% jump, so the cause remains unclear without additional context on volume, technicals, or delayed announcements.

WBUY Global Ltd traded at $0.89 with a substantial single-day gain of 17.43%, ranking it as the 33rd biggest gainer on the snapshot date. However, no news headlines from Yahoo Finance RSS in the preceding 48 hours are available to point to a specific catalyst. At this low price level, the stock could respond to several types of unannounced events: technical bottoming or short covering, delayed media coverage of an earlier announcement, retail social-media driven interest, or routine micro-cap volatility. Without access to trading volume data, insider activity, or broader market context, attribution remains speculative. A 17% single-day move on a penny stock is not unusual but typically warrants investigation into whether volume was elevated and whether any company announcements or regulatory filings were released outside the RSS feed window.

TTGT

TechTarget IncTechnology

$4.47+$0.66

+17.3%

NASDAQ · Mkt cap $271 M

No headlines from the last 48 hours are available to explain TechTarget's 17.32% gain, so the driver remains unclear; the move may reflect delayed news pickup, technical trading, or a market-moving announcement not yet syndicated to the RSS feed.

Yahoo Finance RSS shows zero headlines in the 48-hour window preceding this snapshot, which is unusual for a stock jumping into the top 35 daily gainers. This gap suggests either that material news has not yet been picked up by mainstream financial media, that the move is driven by technical factors or intraday sentiment shifts, or that a news event occurred but has not propagated to the tracked RSS sources by the snapshot time. TechTarget is a B2B marketing and technology research company; moves of this magnitude typically correlate with quarterly earnings surprises, subscriber growth announcements, margin guidance revisions, or acquisition activity. Without headlines, we cannot confirm which of these or other catalysts is at work.

FIRY

Firy Inc.Communication Services

$9.83+$1.41

+17.3%

NYSE · Mkt cap $163 M

Firy Inc. surged 17.3% after a federal court ordered Papaya Gaming to pay the company $719 million for false advertising, representing a major legal victory and substantial financial gain.

The headline clearly documents a post-trial court order requiring Papaya Gaming to disgorge $719 million in unjust profits to Firy Inc. (formerly Skillz Inc.) for false advertising violations. This is a concrete, material positive outcome: the company wins a large monetary judgment that will flow to its balance sheet, improving financial position and reducing litigation risk. The timing of the announcement on market hours (12:27 UTC) and the magnitude of the award relative to typical stock moves make this a straightforward catalyst. Investors likely repriced the stock upward to reflect both the immediate cash benefit and the removal of legal uncertainty. No negative headlines or offsetting news appear in the provided sources, leaving the positive legal victory as the dominant near-term driver.

EURKR

Eureka Acquisition Corp Right

$0.34+$0.05

+17.2%

ONFO

Onfolio Holdings Inc. Common StCommunication Services

$0.11+$0.02

+16.7%

NASDAQ · Mkt cap $334 K

Onfolio announced it is pursuing strategic alternatives including acquisitions and divestitures to strengthen its portfolio and drive shareholder value, spurring a 16.72% intraday gain on renewed optimism for portfolio transformation.

On July 28, 2026, Onfolio Holdings released two nearly simultaneous press releases announcing it is actively exploring strategic alternatives to reshape its business. The stated goal is to strengthen the portfolio and maximize shareholder value through acquisitions, transformational transactions, and potential asset sales. For a micro-cap stock trading at $0.11, such an announcement signals potential catalysts ahead—either meaningful M&A activity, operational restructuring, or both—that could unlock value currently priced into the stock. The timing and dual releases suggest the company is serious about execution. Investors interpreted this as a positive inflection point, driving the day's strong gain. Without details on specific targets, timelines, or deal sizes, the move reflects sentiment shift around growth prospects rather than certainty of any particular outcome.

Shoulder Innovations, Inc.Healthcare

$24.37+$3.41

+16.3%

NYSE · Mkt cap $397 M

No news headlines were found in the last 48 hours for Shoulder Innovations, so the 16.27% gain cannot be directly attributed to a reported catalyst. The move likely stems from technical trading, delayed news dissemination, or unconfirmed market rumors.

The absence of any news in the provided Yahoo Finance RSS feed over the last two days makes it impossible to ground the explanation in a specific catalyst. For a smaller-cap medical device company like Shoulder Innovations, a 16% single-day move without concurrent headline coverage could reflect several possibilities. This could be a technical rebound after prior weakness, short covering if the stock has significant short interest, or a delayed market reaction to news that has not yet propagated to major financial feeds. Alternatively, the catalyst may exist but simply was not captured in the 48-hour window provided, or an earnings beat, FDA approval, or partnership announcement may have occurred but the formal headline has not yet been indexed by Yahoo Finance's RSS aggregator. Without access to real-time trading data, insider filings, or company press releases, the specific driver remains unknown.

KNRX

KNOREX LTD.Technology

$0.48+$0.07

+16.0%

NYSE · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 15.98% gain on KNOREX LTD. likely stems from technical trading activity, delayed news dissemination, or market rumors rather than a confirmed corporate announcement.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for KNOREX's strong single-day move. A 16% rally in a stock trading near $0.48 could reflect several dynamics typical of lower-priced securities: short covering or a squeeze, retail momentum trading, delayed reporting of earnings or partnership announcements, technical breakout above a resistance level, or sector-wide strength in digital marketing or advertising technology if KNOREX operates in that space. Without access to intraday social media sentiment, institutional positioning, or the company's earnings calendar, we cannot confidently attribute the move to any particular fundamental event. The timing gap between the price action and available news suggests either that the catalyst has not yet been widely reported through mainstream channels or that the move is driven by non-news factors.

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.02+$0.00

+15.9%

NASDAQ

No news headlines were found in the last 48 hours. The 15.89% gain in BNCWW, a warrant security, likely reflects technical trading activity, potential short covering, or delayed market reaction to an earlier untracked announcement.

BNCWW is a warrant issued by CEA Industries, a leveraged security that amplifies price moves in the underlying equity. With no recent news identified in the provided headlines, the sharp intraday gain could stem from several structural factors typical of warrant trading: thin liquidity and low absolute price creating outsized percentage swings from modest dollar moves, short covering or squeeze dynamics, technical mean reversion after prior weakness, or delayed market reaction to a news event that occurred outside the 48-hour window or was not captured by the RSS feed. Warrants are particularly sensitive to implied volatility and time decay, meaning external catalysts in the parent company CEA Industries may drive the move even if not explicitly flagged here. Without access to trading volume, short interest, or parent company news, attribution remains speculative.

ANY

Sphere 3D CorpFinancial Services

$2.18+$0.30

+15.8%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 15.79% gain on ANY stock likely reflects either a delayed market reaction to earlier developments, technical buying, or unindexed corporate news not yet captured by Yahoo Finance RSS feeds.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for the jump. Sphere 3D is a small-cap technology company focused on infrastructure and cloud solutions, sectors that can be sensitive to technical trading, short covering, or market sentiment shifts even without major announced catalysts. The stock's modest price level and ranking as the 41st biggest gainer suggests this could reflect either modest retail or algorithmic buying activity in a lower-volume name, or possibly a delayed market reaction to news released before the 48-hour window. Without access to press releases, SEC filings, or trading data, distinguishing between technical momentum, short squeeze behavior, and undiscovered fundamental news is not possible from the information provided.

INLF

INLIF LIMITEDIndustrials

$5.27+$0.69

+15.7%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours for INLIF, so the cause of the 15.68% gain cannot be determined from public announcements; the move likely reflects technical trading, delayed news pickup, or untracked catalysts.

The absence of any recent news headlines in the Yahoo Finance RSS feed makes it difficult to pinpoint a specific catalyst for INLIF's strong 15.68% single-day gain to $5.27. For a small-cap or micro-cap stock trading on NASDAQ, price moves of this magnitude in the absence of tracked news could stem from several common scenarios: short covering or technical momentum reversal, a delayed or regional news announcement not yet reflected in major feeds, retail trading interest concentrating on the name, an earnings release or guidance revision, or corporate actions such as insider buying or strategic announcements that have not yet propagated through mainstream financial news sources. Without corroborating headlines or structural information about INLIF itself, only inference about the category of cause is possible rather than identification of a specific event.

MEDS

Trxade Group IncHealthcare

$3.58+$0.46

+14.7%

NASDAQ · Mkt cap $4.4 M

No news headlines were reported in the last 48 hours for MEDS, so the 14.74% gain cannot be directly attributed to a disclosed catalyst. The move may reflect technical trading, a delayed market reaction to prior news, or undisclosed material developments.

Trxade Group (MEDS) jumped 14.74% to rank among the day's top 43 gainers, but no recent news articles appear in the search results from the past 48 hours. This disconnect between price action and headline visibility is common in smaller-cap stocks. Possible explanations include a technical reversal or short covering in a stock that may trade with lower liquidity, a delayed market reaction to earlier announcements not yet indexed in RSS feeds, or an undisclosed material event such as an acquisition rumor, partnership, or guidance update not yet widely reported. Trxade operates in the healthcare distribution and e-commerce space, so catalysts could range from business development to regulatory or licensing updates. Without corroborating news, the exact driver remains unclear.

IQV

IQVIA Holdings IncHealthcare

$243.31+$30.05

+14.1%

NYSE · Mkt cap $44 B

IQVIA surged 14.09% on strong Q2 earnings that beat estimates, record R&D bookings, and a raised full-year 2026 guidance, positioning it as the top gainer in the S&P 500 on the day.

IQVIA reported second-quarter results that exceeded guidance at the high end, driven by accelerating organic revenue growth and record R&D Solutions bookings. The company delivered earnings and revenue surprises of 4.31% and 1.63% respectively against consensus estimates. Management raised its full-year 2026 outlook on the back of these results and cited operational productivity gains and AI-driven advancements as drivers of future growth. The stock surged past a technical buy point following the announcement. Multiple headlines confirm this was the day's primary healthcare sector catalyst, with IQV identified as the best performer in the S&P 500 on this date. The magnitude of the move aligns with a positive earnings surprise combined with raised guidance, which typically triggers institutional repositioning and momentum buying in quality healthcare service providers.

TNMG

TNL Mediagene Ordinary SharesCommunication Services

$0.39+$0.05

+14.0%

NASDAQ · Mkt cap $1.1 M

TNL Mediagene announced full repayment of its senior convertible note to 3i, LP and mutual termination of the note purchase agreement, likely relieving debt pressure and improving the company's financial flexibility, driving the 14% gain.

The headline establishes that TNL Mediagene has completed repayment of principal and accrued interest on a senior convertible note issued in December 2025 and has mutually terminated the underlying agreement with 3i, LP. For a micro-cap stock trading at $0.39, elimination of near-term debt obligations and removal of dilution risk from a convertible instrument can be a meaningful catalyst. The mutual termination suggests the company negotiated favorable terms or secured alternative financing, both positive signals. However, the headline does not disclose the repayment amount, method of funding, or any forward guidance, so the magnitude of financial benefit remains unclear from the available evidence.

CLVT

Clarivate PlcTechnology

$2.42+$0.30

+13.9%

NYSE · Mkt cap $1.3 B

No news headlines were found in the last 48 hours, so the 13.92% jump cannot be directly attributed to a reported event. The move likely reflects technical buying, delayed market reaction to an earlier announcement, or unconfirmed rumors in the market.

The absence of recent headlines makes it impossible to pinpoint a specific catalyst for CLVT's strong 13.92% gain today. Clarivate is a life sciences and intellectual property information company that typically responds to earnings releases, product announcements, acquisition news, or analyst upgrades. Given the magnitude of the move and its rank as the 46th biggest gainer, the catalyst could be a delayed market reaction to news that broke prior to the 48-hour window, positive sector momentum in information services or life sciences, short-covering, or technical factors like oversold conditions triggering a rebound. Without confirmed news, any explanation remains speculative.

GSRVR

GSR V Acquisition Corp.

$1.46+$0.17

+13.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 13.18% gain cannot be tied to a specific announcement. The move likely reflects either technical trading activity, a delayed market reaction to older news, or market chatter not yet picked up by major news feeds.

GSR V Acquisition Corp. is a blank-check acquisition company (SPAC), which typically trades near NAV until a business combination is announced or completed. A 13.18% single-day jump on no reported news is unusual for a SPAC and suggests one of several possible drivers: a merger announcement or deal progress that has not yet appeared in the headline feed, short covering or technical momentum trading, retail buying following social media attention, or a rights offering or distribution that affects the share price mechanically. Without confirming headlines, any explanation remains speculative. SPACs are particularly prone to sharp moves on rumor or insider activity before formal news disseminates, so timing lag between the move and headline availability is plausible but cannot be verified here.

FSUN

FirstSun Capital BancorpFinancial Services

$39.31+$4.56

+13.1%

NASDAQ · Mkt cap $1.8 B

FirstSun Capital Bancorp jumped 13.12% following a $150 million share repurchase authorization announced alongside Q2 earnings, signaling confidence despite a quarterly net loss driven by merger integration costs.

FirstSun reported a $22.9 million net loss in Q2 2026, down sharply from $26.4 million profit in Q2 2025, primarily due to merger-related expenses and elevated credit provisions following an April acquisition. While the earnings miss is negative, the company's board authorized a $150 million share repurchase program on the same announcement date. This buyback authorization likely drove the stock jump, as it signals management confidence in intrinsic value despite near-term earnings headwinds and suggests capital adequacy post-merger. Regional bank stocks often respond positively to share repurchase programs because they can support EPS accretion and indicate management believes the stock is undervalued. The 13% gain reflects investor optimism that merger integration challenges are temporary and that the combined entity will generate sufficient capital return and earnings growth over time.

CMRC

BigCommerce Holdings, Inc. - Series 1Technology

$3.20+$0.36

+12.7%

NASDAQ · Mkt cap $178 M

BigCommerce announced that Waterco, a major pool products manufacturer with 45,000 SKUs, launched a digital B2B ordering platform on its infrastructure, replacing manual ordering; this customer win drove a 12.68% share price jump.

The news that Waterco—a global manufacturer—modernized its B2B ordering by deploying BigCommerce's platform is a concrete use-case win demonstrating the software's ability to handle large product catalogs and complex B2B workflows. The announcement highlights operational benefits: simplifying purchasing for customers and streamlining operations for the vendor. This represents both a new customer acquisition and validation of BigCommerce's competitive position in the B2B e-commerce segment. The timing of the jump (shares rose 6.2% intraday on July 28 following the July 27 announcement) aligns directly with the news release. While the headline does not specify contract value or multi-year terms, customer wins of this scale—especially replacing legacy manual processes—are typically viewed as positive indicators for SaaS platform adoption and expansion.

WLDS

Wearable Devices LtdTechnology

$3.71+$0.40

+12.5%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours for WLDS, so the 12.54% gain likely reflects technical trading, a delayed announcement not yet indexed by Yahoo Finance, or renewed retail interest in wearable device stocks.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for WLDS's strong 12.54% daily gain. Wearable device companies can be sensitive to several types of catalysts that may not always appear immediately in mainstream financial news feeds: product launch announcements or leaks, insider buying activity, analyst upgrades or coverage initiations, sector-wide momentum in health tech, or speculation tied to partnerships or distribution deals. Given that WLDS ranks as the 50th biggest gainer of the day, this suggests either a material event that Yahoo Finance has not yet indexed, technical factors such as short covering or momentum trading in a lower-volume stock, or a broader sector rotation into wearables. Without headlines or structural details, the true cause remains unclear.

Biggest Losers

Tue, Jul 28, 2026 50

AACI

Armada Acquisition Corp. IFinancial Services

$2.31−$7.69

-76.9%

NASDAQ · Mkt cap $341 M

No news headlines were available in the last 48 hours, but a 76.93% single-day collapse in a SPAC suggests either a failed merger announcement, regulatory rejection, or major insider development that has not yet appeared in public news feeds.

Armada Acquisition Corp. I is a special purpose acquisition company (SPAC), a structure highly sensitive to deal-related catalysts. The extreme magnitude of this single-day drop—nearly 77%—is inconsistent with normal market volatility and suggests a discrete, material event. Possible categories include termination or failure of a planned merger target, regulatory or shareholder disapproval of a proposed combination, insider redemptions, or a major negative announcement by management. SPACs typically trade near $10 per share at IPO and decline toward $5 if no deal closes; a price of $2.31 indicates the stock has fallen well below typical liquidation value, which would occur only if investors foresaw imminent or catastrophic loss of capital. Without access to news headlines from the last 48 hours, the specific trigger cannot be identified, but the magnitude points firmly toward a deal-breaking event rather than technical selling or sector-wide weakness.

YYAI

Connexa Sports Technologies Inc.Technology

$0.91−$2.19

-70.8%

NASDAQ · Mkt cap $3.9 M

AiRWA Inc. announced a $130 million acquisition of Best Life, an import-export company, to diversify beyond its AI business, but the market reaction was sharply negative, likely driven by concerns about the deal's valuation, execution risk, or dilution to existing shareholders.

The headline material establishes that AiRWA (ticker YYAI) announced a definitive agreement to acquire Hongkong Best Life Trade Co., Limited on July 27, 2026. The deal structure includes upfront payments plus performance-based earn-outs totaling up to $130 million. The stated rationale is to diversify revenue streams beyond the company's AI data training business. However, the market's 70.76% single-day sell-off suggests investors view this negatively. Possible drivers include skepticism about overpaying for a non-core asset, concerns about management's capital allocation priorities, uncertainty about earn-out realization, or fears of significant shareholder dilution to fund the transaction. Without detailed deal terms, financing structure, or analyst commentary, we cannot pinpoint the specific objection, but the magnitude of the decline indicates this was seen as materially value-destructive by the market.

BIOT

Biotech Acquisition CompanyConsumer Defensive

$1.30−$1.47

-53.1%

ENLV

Enlivex Therapeutics LtdHealthcare

$2.25−$2.00

-47.1%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 47% single-day drop cannot be attributed to a disclosed event; the cause remains unclear without additional reporting.

Enlivex is a clinical-stage immunotherapy company, and a collapse of this magnitude in a single day on a micro-cap biotech stock typically signals one of a few catalyst types: delayed or failed clinical trial results, an unexpected insider selloff or dilutive financing announcement, regulatory setback, or significant short-covering reversal. Without news coverage in the RSS feed, the trigger event may not yet be widely reported, may have occurred after market close on July 27, or may be a non-public rumor affecting trading. Biotech stocks of this size are also more prone to technical liquidation or algorithmic selling in low-volume conditions. The absence of any headline to explain a 47% move is itself noteworthy and suggests either a gap in news coverage or a development that has not yet reached major financial news sources.

SPWR

SunPower CorpTechnology

$0.29−$0.20

-41.6%

NASDAQ · Mkt cap $46 M

SunPower reported Q2 2026 results showing revenue decline due to delayed residential solar installations, prompting the 41% sell-off despite management's guidance for Q3 recovery and cost-cutting measures.

SunPower released second-quarter 2026 earnings on July 28 showing weaker-than-expected revenue driven by installation delays in its residential solar business. The headlines indicate management outlined operational changes and cost reductions aimed at improvement, with a forecast of $10 million operating income improvement in Q3 2026. The sharp 41% single-day decline suggests investors reacted negatively to the magnitude of the Q2 revenue miss and the near-term weakness, despite management's recovery narrative for Q3. The market appears to have focused on current operational challenges and delayed installations rather than on the forward guidance or restructuring efforts. At $0.29 per share, SPWR is trading at extreme distress levels, indicating the stock had already suffered significant prior declines, making it highly sensitive to earnings disappointments.

REPL

Replimune Group IncHealthcare

$5.35−$3.29

-38.1%

BRUNW

Boost Run Inc. Warrant

$5.25−$2.58

-33.0%

CJMB

Callan JMB Inc. Common StockIndustrials

$1.83−$0.84

-31.5%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 31.46% drop on CJMB cannot be attributed to a specific announced event. The move likely stems from a technical, earnings-related, or market-sentiment catalyst that was not captured in the available news feed.

The absence of recent news headlines makes it difficult to pinpoint the exact cause of CJMB's sharp 31.46% decline. This scale of single-day loss typically reflects either a material corporate announcement (earnings miss, guidance cut, insider selling, delisting risk), a technical liquidation or short squeeze reversal, or delayed market reaction to news that circulated outside mainstream financial feeds. Without visibility into earnings releases, regulatory filings, insider transactions, or broker downgrades, the most likely categories are a negative earnings surprise or dividend cut, a significant share dilution event, adverse industry or sector rotation, or algorithmic unwinding of a prior rally. The stock's low absolute price of $1.83 and small-cap status suggest it may be subject to higher volatility and lower news coverage, making it plausible that a major catalyst occurred but was not syndicated through the sampled news sources.

CELG.RI

Bristol-Myers Squibb Company Ce

$0.08−$0.04

-31.1%

CODX

Co-Diagnostics IncHealthcare

$1.40−$0.63

-31.0%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics fell 31% despite announcing positive news about its Ebola test development and successful proof-of-concept; the disconnect suggests market pessimism about commercialization prospects or other negative developments not reflected in the provided headlines.

The two headlines released on July 28th report favorable technical progress: CoSara Diagnostics (the company's Indian joint venture) shipped evaluation kits for an extraction-free Ebola test and announced a successful proof-of-concept. These are typically constructive announcements for a diagnostic company. However, a 31% single-day collapse indicates the market either disbelieves the commercial viability of these results, questions the financial health of the company, or is reacting to negative information not captured in the provided news summaries. Possible explanations include disappointing quarterly results, delayed revenue generation, funding concerns, competitive threats, or a broader sector selloff. The timing of announcements alongside the crash is unusual and suggests either the market anticipated worse news or information gaps exist in the provided headlines that would explain investor capitulation.

INVZ

Innoviz Technologies Ltd.Consumer Cyclical

$0.44−$0.19

-30.2%

NASDAQ · Mkt cap $107 M

Innoviz announced a $30 million registered direct offering on the morning of July 28, which typically triggers immediate shareholder dilution concerns and explains the 30% single-day drop.

The company announced pricing of a $30 million registered direct offering, a capital raise that involves the issuance of new shares directly to investors at a negotiated price. This type of announcement almost always triggers selling pressure because existing shareholders face immediate dilution of their ownership stake and earnings per share. The timing of the announcement at 12:42 UTC on the same day as the massive price decline strongly suggests market reaction to the offering news itself. Registered direct offerings are often viewed negatively by the market relative to other fundraising methods because they bypass traditional equity offerings and can signal management's view that the current stock price is attractive enough to raise capital at. Given that INVZ is a small-cap semiconductor/LiDAR company with limited liquidity, the relative size of the $30 million raise likely amplified the negative reaction.

DSX.WT

Diana Shipping Inc. WT

$0.15−$0.06

-28.5%

BCAR

D. BORAL ARC ACQUISITION I CORPFinancial Services

$5.64−$2.20

-28.0%

NASDAQ · Mkt cap $226 M

No news headlines were found in the last 48 hours to explain the 28% drop in BCAR, a SPAC, so the cause remains unclear from available public information.

D. Boral Arc Acquisition I Corp is a SPAC shell company, and the absence of any news headlines in the past 48 hours makes it difficult to pinpoint a specific catalyst for the sharp 28% decline. SPACs can be volatile due to several structural factors: redemption announcements before a merger vote, deteriorating deal economics, investor redemptions ahead of a shareholder meeting, or unfavorable merger termination news. Without headlines, the move could reflect a scheduled event (merger vote, redemption window closing, deal announcement delay) or market-wide sector rotation out of blank-check companies. It is also possible that material news exists but has not yet been picked up by major RSS feeds, or the decline reflects intraday trading dynamics in a thinly-traded security.

NAUT

Nautilus Biotechnology, Inc.Healthcare

$1.20−$0.47

-28.0%

NASDAQ · Mkt cap $114 M

Nautilus Biotechnology reported Q2 2026 earnings on July 28 and announced a strategic shift in R&D toward proteoform applications, combined with a delay in its Broadscale broad-proteome product, triggering a 28% sell-off likely driven by concerns over delayed commercialization and execution risk.

The earnings call highlights reveal two material developments: first, the company is reallocating significant R&D resources away from its flagship Broadscale broad-proteome platform toward proteoform applications, citing customer interest but effectively acknowledging a delay in the core product. Second, the company faces unspecified financial challenges mentioned in the headlines. For a pre-revenue or early-stage biotech platform company, a delay in the lead product combined with a pivot in strategy is typically interpreted as a loss of confidence in the original business plan and raises questions about near-term revenue generation and cash runway. Investors appear to have reacted negatively to both the delay announcement and the implicit admission that the original strategy required course-correction. The stock's position as the 14th biggest loser suggests this was a market-wide reaction to the earnings news rather than a sector-wide decline.

ADVB

Advanced Biomed Inc. Common StockHealthcare

$10.48−$4.00

-27.6%

NASDAQ · Mkt cap $14 M

Advanced Biomed Inc. fell 27.62% on July 28, 2026, with no news headlines available in the last 48 hours to explain the move, suggesting the catalyst may be delayed reporting, an after-hours announcement, or unspecified market conditions.

No news headlines were found in the last 48 hours to account for this substantial single-day loss. For a biomedical company trading on NASDAQ, a 27.62% drop typically correlates with material negative events such as clinical trial results, FDA rejection or warning, loss of a major partnership, guidance reduction, or insider sales. Without available headlines, the cause remains unclear. The timing suggests either that news was released outside the capture window, appeared on channels not indexed by Yahoo Finance RSS, or that the move reflects technical selling, short covering, or market conditions unrelated to company-specific news. The absence of any corroborating headlines despite a top-15 loss ranking is notable and limits confidence in pinpointing a specific catalyst.

TZOO

TravelzooCommunication Services

$7.55−$2.64

-25.9%

NASDAQ · Mkt cap $73 M

Travelzoo reported Q2 2026 results with a loss and revenue miss on 2026-07-28, citing geopolitical uncertainty and headwinds to travel demand, triggering a 26% sell-off as the market repriced the stock lower on disappointing earnings.

Travelzoo released second-quarter earnings on July 28, 2026, posting a net loss and revenue of $23.2 million, down 3% year-over-year and missing estimates by 7.72%. The earnings surprise was negative at -240%, indicating a substantial miss on the bottom line. The headlines consistently cite two material headwinds: international conflicts depressing travel demand and advertiser sentiment, plus continued investment in a paid membership strategy that weighed on near-term profitability. While management maintained forward expectations according to one headline, the combination of a significant loss, revenue decline, and macroeconomic headwinds created a strong catalyst for a sharp downward repricing. The stock ranks 16th among the day's biggest losers, consistent with earnings-driven capitulation in a travel-adjacent business facing both cyclical demand pressure and strategic near-term margin pressure.

FVN

Future Vision II Acquisition Corporation Ordinary sharesFinancial Services

$9.07−$3.16

-25.8%

NASDAQ · Mkt cap $88 M

No news headlines were found in the last 48 hours, so the 25.81% drop cannot be attributed to a publicly reported event; the decline likely stems from an announcement or market event not yet captured by the news feed, or broad market/sector weakness.

The absence of any news in the 48-hour window preceding this sharp 25.81% decline is notable. FVN is a SPAC (Special Purpose Acquisition Company), a blank-check vehicle that typically trades near NAV ($10.00 per share) until a business combination is announced or completed. A drop from approximately $12.20 to $9.07 suggests either a deal announcement at unfavorable terms, news of a failed merger negotiation, regulatory issues, or shareholder dilution concerns. It is also possible that an insider filing, SEC action, or material event occurred between market close on 2026-07-27 and the snapshot date that has not yet appeared in the RSS feed or that market participants reacted to late-breaking information not yet indexed. Without corroborating headlines, structural SPAC dynamics point to merger-related news as the likeliest category of catalyst.

ZVZZT

$11.52−$3.90

-25.3%

GOSS

Gossamer Bio IncHealthcare

$0.21−$0.07

-25.0%

NASDAQ · Mkt cap $77 M

Gossamer Bio surged 25% on July 27 following positive FDA regulatory news and seralutinib rights reacquisition, but reversed sharply on July 28 despite pre-bell reports of new drug application filing plans, suggesting either a disappointed earnings call, clinical trial setback, or market exhausti…

The timeline shows a major contradiction. On July 27, the stock jumped 25% after FDA regulatory approval and global rights reacquisition for seralutinib, clearly positive catalysts. The July 28 headline mentions the company extending gains pre-bell with new drug application filing plans, which should also be positive. Yet the stock closed down nearly 25% on July 28, erasing the previous day's gain entirely and ranking it among the day's biggest losers. This suggests either the full-day trading revealed disappointing clinical details, negative guidance on the drug candidate's commercial prospects, a failed earnings call despite the headline, or a sharp pullback from retail traders who bought on the euphoria. Without access to intraday details or the full press release, the exact catalyst for the reversal remains unclear, though the magnitude suggests the market reassessed fundamentals rather than technical mean reversion alone.

SHAZ

SharonAI Holdings Inc.Technology

$44.91−$13.92

-23.7%

NASDAQ · Mkt cap $2.0 B

SHAZ dropped 23.66% on news that Q2 2026 earnings will be announced after market close on August 6, likely due to investor anxiety ahead of results or a pre-announcement warning signal not captured in the headline.

The only headline provided is an announcement that Sharon AI will release second quarter 2026 financial results on August 6, 2026. This is a standard earnings release notice with no indication of a guidance cut, warning, or negative pre-release comment. The timing does not explain a 23.66% same-day drop, since earnings announcements typically cause volatility on the announcement date itself, not days before. The decline could reflect investor concern about expected results, short-selling ahead of earnings, or a separate negative catalyst entirely that is not captured in the provided headlines. Without access to the full earnings release, analyst downgrades, insider selling, or other material news from the past 48 hours, the root cause remains unclear from the evidence supplied.

NXL

Nexalin Technology IncHealthcare

$0.34−$0.10

-23.3%

NASDAQ · Mkt cap $7.3 M

No news headlines were found in the last 48 hours to explain NXL's 23.27% decline, so the cause is unknown; the drop likely stems from either a delayed news event, technical selling, or market sentiment shift in a micro-cap stock.

Nexalin Technology is a micro-cap stock trading at $0.34, and the absence of any news in the last 48 hours makes direct attribution impossible. Micro-cap and penny-stock securities are particularly susceptible to sharp moves driven by factors outside traditional news flow, including retail trading momentum shifts, options expiration effects, short covering reversals, or broader sector rotation out of lower-liquidity names. It is also possible that a significant announcement or earnings report was released slightly outside the 48-hour window captured here, or that news broke after market close or on alternative venues. Without access to intraday developments or company filings, we cannot pinpoint the specific trigger for this 23% sell-off, only note that it ranks as one of the day's largest declines.

POLA

Polar Power IncIndustrials

$1.64−$0.48

-23.1%

NASDAQ · Mkt cap $6.9 M

Polar Power announced a $25 million committed equity facility on July 27, but the stock fell 23% the next day, suggesting investors reacted negatively to the dilutive nature of the equity raise or concerns about the company's working capital needs.

The headline on July 27 announced that Polar Power secured up to $25 million in committed equity financing to support growth in DC power systems, data-center power, cooling, and drone-charging operations. On the surface this appears positive—new capital for expansion. However, a 23% single-day drop following an equity facility announcement typically signals investor concern about shareholder dilution from the equity component of the raise, questions about why the company needed to tap the market despite prior claims of organic growth momentum, or market skepticism about the addressable market for these products. Without access to the full press release details (pricing, warrant terms, conversion rates), we cannot determine whether the dilution is severe or whether the market simply repriced growth expectations downward. This is a micro-cap stock prone to volatile reactions to capital events.

AGRZ

Agroz Inc.Consumer Defensive

$0.22−$0.07

-22.8%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours for Agroz Inc., so the 22.8% drop on 2026-07-28 cannot be attributed to any identifiable public announcement or reported event. The decline likely reflects technical selling, delayed news, or broader market pressure.

The absence of recent news makes direct attribution impossible. Agroz trades at a very low price point ($0.22), which is typical of microcap or penny stocks that can experience volatile swings on minimal volume, technical factors, or unconfirmed rumors that may not yet appear in mainstream financial news feeds. Possible explanations include a delayed earnings announcement or guidance revision not yet published by major outlets, an insider transaction or regulatory filing that precedes news coverage, broader sector weakness affecting small-cap agricultural plays, or algorithmic or retail selling pressure unrelated to fundamentals. Without access to company filings, news wires beyond Yahoo Finance, or real-time trading data, we cannot distinguish between these scenarios.

VCIG

VCI Global Limited - Ordinary ShareIndustrials

$0.34−$0.10

-22.1%

NASDAQ · Mkt cap $2.4 M

No relevant news was found in the last 48 hours, so the 22% drop likely stems from a delayed market reaction to an earlier announcement, technical selling, or broad sector pressure that has not yet been reported in available headlines.

The absence of news in the last 48 hours makes it impossible to pinpoint a specific catalyst for VCIG's sharp 22% decline on July 28, 2026. VCI Global Limited trades on NASDAQ as a micro-cap stock at $0.34, a price level typical of distressed equities, which are often subject to higher volatility and lower liquidity. The move could reflect a delayed market reaction to an earlier earnings miss, insider selling, shareholder dilution, or operational setbacks announced before the snapshot date. Alternatively, the decline may reflect sector-wide pressure unrelated to company-specific news, or technical selling related to support levels breaking. Without current headlines or structural information about pending events, we cannot reliably distinguish among these possibilities.

GXAI

The NFT Gaming Company, Inc.Communication Services

$0.84−$0.23

-21.3%

NASDAQ · Mkt cap $9.2 M

Gaxos announced a strategic gaming divestiture to refocus on AI and health platforms, signaling a pivot away from its legacy NFT gaming business and likely disappointing investors who held the stock for that segment.

On July 28, Gaxos announced it is divesting its gaming business to sharpen focus on revenue-generating AI and health-and-wellness platforms. The headline framing emphasizes "commercial traction and customer acquisition efficiency" as the rationale. While the company reported Q1 revenue of $1.81 million, the divestiture itself appears to be the market-moving catalyst. For a company trading under the ticker symbol GXAI (The NFT Gaming Company), divesting the gaming segment represents a fundamental business model shift that contradicts the company's stated identity and core investor thesis. This announcement likely triggered a wave of sell orders from holders who bought into the gaming or NFT narrative and view the pivot as a dilution of that bet or an admission that gaming operations were underperforming. The 21.3% single-day drop reflects swift repricing of expectations around the company's growth trajectory and revenue sources.

MWYN

Marwynn Holdings, Inc. Common stockConsumer Cyclical

$0.53−$0.14

-20.4%

NASDAQ · Mkt cap $21 M

No news headlines were published in the last 48 hours for MWYN, so the 20% drop likely reflects technical selling, a delayed market reaction to an earlier announcement, or untracked micro-cap volatility.

The absence of any recent news headlines in the last 48 hours makes it impossible to identify a specific catalyst for the 20.41% decline. MWYN is a micro-cap stock trading at $0.53, and such securities are prone to outsized moves on minimal trading volume, technical breakdowns, or news that may not be captured in major financial feeds. The drop could reflect a delayed market reaction to company news released earlier in the week, negative sentiment in a related sector, or simply thin liquidity amplifying a small sell order. Without access to company filings, press releases directly from MWYN, or confirmation of any after-hours developments, any explanation remains speculative.

AGMH

AGM Group Holdings IncTechnology

$0.80−$0.21

-20.4%

NASDAQ · Mkt cap $2.2 M

No news was available in the last 48 hours to explain the 20.38% drop in AGMH stock, so the cause remains unclear without additional reporting on company-specific events, market conditions, or sector dynamics.

Yahoo Finance returned no headlines for AGMH in the past two days, which means we cannot attribute the sharp decline to any announced earnings miss, guidance cut, regulatory action, or corporate event covered by major news outlets. A penny stock trading at $0.80 with this magnitude of single-day loss could plausibly have moved on several categories of catalyst: a delayed or surprise press release not yet indexed by RSS feeds, technical selling or forced liquidation in a low-liquidity name, sector rotation out of small-cap equities, or a development disclosed directly by the company but not yet picked up by financial news aggregators. Without access to the company's investor relations channels or real-time trading information, we cannot distinguish between these scenarios.

IAUX.WT

i-80 Gold Corp. WT

$0.72−$0.18

-20.0%

ZIVO

Zivo Bioscience, Inc.Healthcare

$4.00−$1.00

-20.0%

NASDAQ · Mkt cap $17 M

ZIVO dropped 20% with no news reported in the last 48 hours, making the specific catalyst unclear; the decline likely stems from a delayed announcement, technical selling, or market-wide biotech weakness rather than identifiable company-specific news.

No headlines were found in the Yahoo Finance RSS feed for the last 48 hours surrounding ZIVO's sharp 20% decline. This absence of contemporaneous news makes pinpointing the exact catalyst difficult. Biotech stocks, particularly smaller-cap firms like ZIVO, are sensitive to several categories of unreported or delayed-to-surface events: clinical trial results or negative interim data released via press release rather than wire service pickup, insider selling or a shareholder filing made public but not yet indexed in headline aggregators, sector rotation out of biotech due to interest rate expectations or broader market conditions, or short-term technical selling following an earlier rally. Without access to the company's investor relations page or SEC filings made today, it is impossible to distinguish between these hypotheses. The fact that ZIVO ranks 29th in daily losers suggests this was a material single-stock move rather than a pure sector collapse.

CVLT

CommVault Systems IncTechnology

$120.01−$29.22

-19.6%

NASDAQ · Mkt cap $5.7 B

CommVault beat Q1 earnings and revenue estimates with strong SaaS growth and raised guidance, yet the stock crashed 20% due to disappointing forward guidance for Q2 and analyst concerns about limited near-term catalysts despite the beats.

CommVault reported first-quarter fiscal 2027 results that exceeded Wall Street forecasts on both earnings and revenue, with 71% free cash flow growth and robust subscription revenue expansion. The company also announced a strategic partnership with Microsoft for cloud-native offerings. However, the stock fell sharply because forward guidance disappointed investors. Piper Sandler downgraded its thesis, citing limited catalysts ahead after the quarter. The disconnect between strong historical performance and weak forward outlook triggered a classic sell-the-news reaction, where investors focused on the lack of upside surprise in future quarters rather than celebrating current beat metrics. This pattern is common in software stocks where growth deceleration or guidance misses weigh more heavily than past achievement.

DAIC

CID HoldCo, Inc.Technology

$1.02−$0.26

-19.4%

NASDAQ · Mkt cap $508 K

No news headlines were published in the last 48 hours to explain the 19.35% drop in DAIC, so the cause remains unclear without additional information about company announcements, earnings, or market events.

The absence of any news in the last 48 hours makes it impossible to tie this 19.35% decline to a specific catalyst. DAIC is a micro-cap healthcare holding company that typically moves on clinical trial results, regulatory decisions, partnership announcements, or earnings releases. The sharp one-day loss could reflect a delayed market reaction to older news, a pre-announcement selloff based on rumor or insider knowledge, technical selling pressure, or a sector-wide downturn affecting smaller healthcare equities. Without access to news wires, SEC filings, or company press releases beyond the Yahoo Finance RSS feed provided, determining whether this was driven by fundamental company news, broader market dynamics, or trading mechanics remains speculative.

PLRZ

Polyrizon Ltd. Ordinary SharesHealthcare

$11.26−$2.64

-19.0%

NASDAQ · Mkt cap $23 M

No news headlines were available in the last 48 hours to explain PLRZ's 18.96% drop, so the catalyst remains unidentified; the decline could stem from earnings disappointment, sector weakness, insider activity, or a delayed news event not yet indexed.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for PLRZ's significant 18.96% single-day decline. Without access to earnings reports, guidance revisions, regulatory actions, or company-specific announcements, several categories of cause are plausible. The stock could have fallen on disappointing quarterly results released outside the 48-hour window, negative sector trends affecting biotech or similar small-cap stocks, or a delayed announcement that has not yet propagated to major news aggregators. Insider selling, analyst downgrades, or short interest accumulation are also possible but unconfirmed by the available data. The magnitude of the drop suggests a material adverse event rather than routine volatility, but the mechanism cannot be determined from the information at hand.

LSTA

Lisata Therapeutics IncHealthcare

$1.18−$0.27

-18.9%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours for Lisata Therapeutics, so the 18.85% decline likely stems from broader market conditions, technical selling, or undisclosed company developments not yet reflected in major news feeds.

The absence of any recent news headlines in the Yahoo Finance RSS feed within the last 48 hours makes it impossible to identify a specific catalyst for the sharp 18.85% drop in LSTA stock. For a small-cap biotech company like Lisata Therapeutics, typical drivers of single-day declines include negative clinical trial results, adverse regulatory decisions from the FDA, delays in product development, capital raise announcements at unfavorable terms, insider selling, or shifts in analyst sentiment. The stock's position as the 33rd biggest loser suggests this was a material move, but without corresponding news it may reflect a delayed market reaction to an earlier announcement, a private event not yet picked up by major news sources, or technical breakdown in a low-volume stock experiencing forced selling or short accumulation.

VTIX

Virtuix Holdings Inc.Technology

$1.67−$0.38

-18.5%

NASDAQ · Mkt cap $55 M

Despite positive news on July 27-28 announcing a Tesla Optimus sale and U.S. Marine Corps counter-drone contract, VTIX fell 18.54%, suggesting the market either discounted the announcements, faced profit-taking after a run-up, or reacted to information not captured in these headlines.

The news flow is unambiguously bullish: Virtuix announced its first enterprise system sale to Tesla's Optimus robot division on July 27, immediately followed by defense expansion into U.S. Marine Corps counter-UAS training on July 28. Both represent milestone commercial and defense wins. However, the stock fell sharply despite these announcements, indicating either that investors had already priced in these wins ahead of the formal releases, that the market viewed the terms or scale of these deals as disappointing relative to expectations, or that an unrelated catalyst—such as broader market weakness, insider selling, analyst downgrade, or guidance revision—drove the move. The headlines do not contain any negative commentary, missed guidance, or cautionary language that would explain the sell-off, leaving a gap between the positive news tenor and the negative price action.

OMH

Ohmyhome Limited - Ordinary SharesReal Estate

$0.15−$0.03

-18.3%

NASDAQ · Mkt cap $7.7 M

Ohmyhome announced closure of a $4 million registered direct offering on July 28, which typically triggers shareholder dilution selling pressure and explains the 18% single-day decline.

The company completed a $4 million registered direct offering, with pricing announced on July 27 and closing confirmed on July 28. Registered direct offerings (RDOs) involve the issuance of new shares at a negotiated price, usually below or near the current market price, directly to institutional or accredited investors. This mechanism creates immediate shareholder dilution and is often viewed negatively by the market because existing shareholders' ownership stakes are reduced and the new shares typically come with minimal lockup restrictions. The timing of the close announcement coinciding exactly with the largest single-day drop ranked 35th among all losers strongly suggests this offering event was the primary driver. For a micro-cap stock like OMH trading at $0.15, even moderate share count increases can have outsized percentage impacts on stock price. No conflicting news about business fundamentals, earnings misses, or other negative catalysts appears in the provided headlines.

FREYR Battery, Inc.Industrials

$4.16−$0.93

-18.1%

NYSE · Mkt cap $1.3 B

T1 Energy announced Q2 2026 preliminary results and an acquisition of solar IP from Evolvolt on July 28, likely triggering the 18% sell-off, though the headlines provided do not disclose the specific financial or operational details that drove the market reaction.

Two corporate announcements from T1 Energy hit the wire this morning: Q2 2026 preliminary results and an acquisition of advanced solar intellectual property from Evolvolt. The timing and magnitude of the decline suggest the market reacted negatively to at least one of these events. However, the news summaries provided are truncated and do not include the actual financial metrics, guidance, or deal terms. The Q2 results could have missed expectations or signaled weaker-than-expected demand or margins in the battery or energy storage business. Alternatively, the solar IP acquisition could have raised concerns about capital deployment, integration risk, or changes to the company's strategic focus. Without the full earnings release or deal details, we cannot determine which announcement or combination thereof caused the sell-off.

SANM

Sanmina CorpTechnology

$172.46−$36.81

-17.6%

NASDAQ · Mkt cap $11 B

Sanmina beat Q3 earnings and revenue estimates with strong AI-driven growth and raised full-year guidance, yet the stock dropped 17.6% likely due to disappointing forward guidance or margin concerns that offset the beat.

The headlines establish that Sanmina reported fiscal Q3 2026 revenue of $3.46 billion, up 69.7% year-over-year, beating Wall Street expectations with a 19.07% earnings surprise and 0.90% revenue surprise. The company highlighted AI infrastructure momentum, ZT Systems integration success, and new customer wins, all of which prompted a raised full-year outlook. However, multiple headlines explicitly note that despite the beat, "next quarter's revenue guidance" or "next quarter's revenue guidance [disappointed]" which directly contradicts the typical stock response to upside beats. The phrase "stock drops" appears in one headline despite the earnings beat, indicating investors reacted negatively to forward-looking metrics. The company also disclosed inventory challenges and evolving market dynamics. This pattern suggests investors repriced the stock downward because guidance for Q4 fell short of expectations, margin trajectory concerned them, or the forward outlook was deemed insufficiently strong relative to the valuation.

BWEN

Broadwind Energy IncIndustrials

$3.97−$0.84

-17.4%

NASDAQ · Mkt cap $115 M

Broadwind Energy dropped 17.38% on July 28, 2026, with no news headlines available in the last 48 hours, suggesting the decline may stem from technical selling, sector headwinds, or undisclosed corporate developments not yet captured in major news feeds.

The absence of any news headlines in the last 48 hours makes it impossible to identify a specific catalyst for the 17.38% decline. Broadwind Energy is a renewable energy equipment manufacturer, typically sensitive to energy policy, order flow announcements, earnings surprises, and sector rotation. A drop of this magnitude without accompanying news coverage could reflect several possibilities: accumulating weakness in renewable energy stocks, a negative development disclosed after hours or through earnings or guidance that has not yet appeared in the RSS feed, technical selling pressure following a run-up, or sector-wide repricing. Without headline data, the true driver remains opaque. The stock's rank as the 38th biggest loser suggests the decline is notable but not extraordinary for a volatile small-cap industrials name.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.75−$0.13

-17.3%

NASDAQ

No news headlines appeared in the last 48 hours to explain the 17.32% drop in Amplitech Series B Rights on July 28, 2026. The move likely reflects broader market conditions, technical trading, or company-specific developments not yet captured in public headlines.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for today's decline. Amplitech Series B Rights are a derivative security tied to the parent company's stock, and rights offerings are particularly sensitive to shifts in investor perception about the underlying business's viability or dilution concerns. The 17.32% drop could reflect several common drivers for this asset class: deterioration in the underlying stock price, news about the company's financial condition or strategic direction announced through channels not captured in the 48-hour window, movement in comparable equities or sector rotation, or reduced retail interest in rights as expiration or exercise deadlines approach. Without concrete headlines, distinguishing between technical weakness and fundamental developments is not possible.

GMEX

GMEX ROBOTICS CORPORATION Class ATechnology

$1.56−$0.31

-17.3%

NASDAQ · Mkt cap $1.0 M

GMEX announced a $52.6 million acquisition of MediaMeta.Ai today, but the market punished the stock with a 17.3% drop, suggesting investor concern about dilution, valuation, or execution risk on the deal.

GMEX issued a press release this morning announcing a definitive agreement to acquire a strategic equity interest in MediaMeta.Ai, touting $52.6 million in expected revenues and exclusive technology rights. On the surface this appears to be a growth-oriented move aimed at expanding robotics capabilities with social intelligence. However, the market's sharp 17.3% selloff indicates skepticism rather than enthusiasm. Possible explanations include concern over acquisition funding and shareholder dilution, uncertainty about MediaMeta's actual profitability or asset quality, questions about integration risk, or a view that the price paid is excessive relative to synergy potential. Without detail on deal structure, purchase price, and financing method, the market may be pricing in worst-case scenarios. The fact that this ranks among the day's 40 biggest losers despite an announced strategic deal underscores that acquisitions do not automatically drive positive returns.

ENTX

Entera Bio LtdHealthcare

$3.26−$0.67

-17.0%

NASDAQ · Mkt cap $153 M

Entera Bio announced a $275M oversubscribed private placement on July 27 that likely triggered dilution concerns among existing shareholders, causing the 17% drop despite the fundraise extending runway into 2030.

The headline announces a completed private placement led by BVF Partners with gross proceeds of $275 million. While the company frames this positively—extending cash runway into 2030 and funding Phase 3 trials for EB613—private placements typically dilute existing shareholders' ownership percentages. Biotech stocks frequently sell off on dilution announcements even when the capital raise is otherwise strategically sound, because the immediate equity dilution outweighs investor confidence in the extended timeline. The magnitude of the 17% drop on the day following the announcement (July 27 announcement, July 28 trading) suggests the market priced in significant dilution concerns. No competing news or countervailing catalyst is visible in the provided headlines to offset this effect.

SXTC

China SXT Pharmaceuticals IncHealthcare

$0.06−$0.01

-17.0%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours, so the 17% drop cannot be attributed to a specific announced event. The decline likely reflects either broad biotech sector weakness, speculative trading in a low-liquidity micro-cap stock, or undisclosed company developments.

The absence of recent news headlines means we cannot pinpoint a concrete catalyst for today's 17% decline in SXTC. For pharmaceutical micro-cap stocks trading at $0.06, moves of this magnitude are common even without public announcements, as these securities are typically thinly traded and highly sensitive to sentiment shifts, technical breakdowns, or sector-wide pressure. Possible drivers include weakness in the broader pharmaceutical or China-focused equity markets, profit-taking after a prior run, or unconfirmed rumors circulating among retail traders. Without access to company filings, insider trading activity, or institutional news sources beyond Yahoo Finance RSS, we cannot determine whether the move reflects fundamentals, technicals, or pure speculation.

BOXL

Boxlight CorpTechnology

$2.99−$0.61

-16.8%

NASDAQ · Mkt cap $3.5 M

Boxlight announced shareholder approval to increase authorized Class A shares on July 28, which typically signals potential dilution and prompted a 16.83% sell-off.

The only headline provided indicates that Boxlight shareholders approved an amendment to increase authorized shares of Class A common stock. While the full details of the announcement were truncated, an increase in authorized shares is commonly interpreted by markets as a precursor to dilution—either through future equity offerings, executive compensation, or strategic transactions. This type of announcement often triggers negative reactions from existing shareholders concerned about earnings-per-share dilution and reduced ownership stakes. The timing of the stock's 16.83% drop on the same day as this announcement suggests a direct causal relationship, though the exact magnitude of the share increase and intended use were not disclosed in the excerpt provided. Without details on whether new shares will be issued immediately or held in reserve, or what the capital-raising purpose might be, investors appear to have interpreted this conservatively.

AMKR

Amkor Technology IncTechnology

$45.69−$9.30

-16.6%

NASDAQ · Mkt cap $12 B

Amkor beat Q2 earnings and revenue estimates with record results and margin expansion, but forward guidance disappointed Wall Street, triggering a 16-23% stock plunge as investors pivot away from AI-related sentiment headwinds and near-term demand caution.

The headlines establish that Amkor reported better-than-expected Q2 results on July 28, 2026, with record $1.90 billion in quarterly revenue (up 25.6% year-over-year), gross margin expansion of 480 basis points, and strength in Computing and Automotive segments driven by AI data center demand. However, multiple sources consistently emphasize that third-quarter guidance "failed to impress Wall Street" and that the stock is under pressure from weak communications segment performance, program delays, and broader AI sentiment caution. B. Riley noted near-term challenges and flagged AI sentiment as an ongoing risk. The disconnect between backward-looking earnings strength and forward-looking weakness, combined with sector-wide tech weakness on the same day, appears to have triggered profit-taking and rerating downward despite the headline earnings beat.

NE.WTA

NE-WTA

$16.56−$3.29

-16.6%

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.07−$0.01

-16.6%

NASDAQ · Mkt cap $4.8 M

No news headlines were found in the last 48 hours to explain RITR's 16.57% drop, making it difficult to identify a specific catalyst for the sell-off on this illiquid micro-cap stock.

The absence of recent news is notable given that RITR dropped 16.57% to trade at $0.07, ranking it among the day's biggest losers. Stocks trading at penny-stock levels with minimal liquidity and market capitalization often experience sharp moves without corresponding news coverage, either because catalysts are company-specific announcements that don't reach mainstream financial headlines, or because the move is driven by technical selling, short covering reversals, or low-volume technical breakdowns. For a logistics-focused company trading at such depressed levels, plausible explanations include delayed quarterly results, margin pressure in the freight or logistics sector, warrant or dilution concerns common to distressed equities, or broader sentiment shifts among retail traders in the microcap space. Without headline evidence, the cause remains speculative.

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$2.07−$0.41

-16.5%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours for LABT, so the 16.53% drop cannot be attributed to any identified public announcement or event. The cause remains unclear without additional market information.

The absence of recent headlines in the 48-hour window makes it impossible to anchor the decline to a specific catalyst. Biotechnology stocks like Lakewood-Amedex are typically sensitive to clinical trial results, regulatory decisions, partnership announcements, or changes in funding outlook. A drop of this magnitude in a small-cap biotech could reflect negative clinical data, an FDA rejection or delay, management changes, dilutive financing news, or broader sector weakness in biotech equities. Without headlines, it is also possible the move resulted from technical selling, short covering reversal, or delayed disclosure of information that reached the market through non-traditional channels before official press release. The timing and size of the move suggest a material negative event, but the specific nature cannot be determined from available evidence.

GSRFR

GSR IV Acquisition Corp. Rights

$1.72−$0.34

-16.5%

NASDAQ

No news headlines were available in the last 48 hours, but GSRFR is a SPAC rights offering which typically loses value as the underlying merger approaches resolution or if investor confidence in the deal weakens.

The 16.5% single-day drop occurred without any identifiable news catalyst in the provided headlines. GSRFR is a rights offering tied to GSR IV Acquisition Corp., a special purpose acquisition company. Rights offerings are inherently time-decaying instruments that approach worthlessness as the SPAC either completes a merger or liquidates. The sharp decline likely reflects either deteriorating sentiment around the underlying deal, expiration dynamics pulling the security lower, or a broader rotation out of SPAC-related positions. Without access to the merger timeline, deal terms, or recent company announcements, we cannot pinpoint whether this is routine decay, a specific deal risk event, or market-wide SPAC sector weakness. The lack of news does not mean there was no catalyst—only that it was not captured in the Yahoo Finance RSS feed provided.

LTCH

Latch, Inc.Technology

$0.15−$0.03

-16.3%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 16.29% decline cannot be attributed to any specific announced event. The drop likely reflects either technical selling pressure, delayed disclosure of bad news, or a market sentiment shift in a micro-cap stock with low liquidity.

Latch is a micro-cap security trading at $0.15 with no recent news coverage in the Yahoo Finance feed, making it difficult to pinpoint a specific catalyst. Stocks at this price point and market cap tier are typically illiquid and prone to sharp moves on minimal volume, technical rebalancing, or late reporting of corporate developments that major newswires may not have immediately captured. The absence of headlines combined with a significant single-day loss suggests either a delayed-disclosure event (earnings miss, insider sales, funding issues), algorithmic or technical selling, or broader micro-cap sector weakness that simply did not trigger major press coverage within 48 hours. Without access to the company's official filings or real-time trading data, we cannot distinguish between these scenarios.

BGIN

Bgin Blockchain LimitedTechnology

$1.76−$0.34

-16.2%

NASDAQ · Mkt cap $225 M

No news headlines were found in the last 48 hours to explain BGIN's 16.19% drop, so the catalyst remains unclear. Blockchain and micro-cap stocks are prone to volatile moves on thin trading, sector sentiment shifts, or unreported developments.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance, regulatory action, or corporate news. For a micro-cap blockchain stock trading at $1.76, a 16% single-day drop is notable but not uncommon given the volatility profile of the sector. Possible explanations include sector-wide weakness in cryptocurrency or blockchain equities, technical selling driven by chart patterns or margin calls, low liquidity amplifying order flow, or an unannounced internal development not yet picked up by major news feeds. Without headline evidence or knowledge of BGIN's specific fundamentals, business model, or recent insider activity, we are limited to inference about generic drivers that move small-cap blockchain stocks rather than identification of the actual cause.